Annual Operating Expenses:
$192.81M-$51.86M(-21.20%)Summary
- As of today, AUPH annual total operating expenses is $192.81 million, with the most recent change of -$51.86 million (-21.20%) on December 31, 2024.
- During the last 3 years, AUPH annual operating expenses has fallen by -$29.76 million (-13.37%).
- AUPH annual operating expenses is now -21.20% below its all-time high of $244.68 million, reached on December 31, 2023.
Performance
AUPH Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Operating Expenses:
$34.62M+$1.17M(+3.49%)Summary
- As of today, AUPH quarterly total operating expenses is $34.62 million, with the most recent change of +$1.17 million (+3.49%) on September 30, 2025.
- Over the past year, AUPH quarterly operating expenses has dropped by -$10.80 million (-23.77%).
- AUPH quarterly operating expenses is now -45.91% below its all-time high of $63.99 million, reached on September 30, 2021.
Performance
AUPH Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
AUPH Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | -21.2% | -23.8% |
| 3Y3 Years | -13.4% | -44.5% |
| 5Y5 Years | +153.6% | -19.9% |
AUPH Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | -21.2% | at low | -45.0% | +32.7% |
| 5Y | 5-Year | -21.2% | +153.6% | -45.9% | +32.7% |
| All-Time | All-Time | -21.2% | +7835.3% | -45.9% | +7931.8% |
AUPH Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $34.62M(+3.5%) |
| Jun 2025 | - | $33.45M(+28.2%) |
| Mar 2025 | - | $26.08M(-42.2%) |
| Dec 2024 | $192.81M(-21.2%) | $45.14M(-0.6%) |
| Sep 2024 | - | $45.41M(-7.3%) |
| Jun 2024 | - | $49.01M(-7.9%) |
| Mar 2024 | - | $53.25M(-11.7%) |
| Dec 2023 | $244.68M(+1.4%) | $60.30M(-1.7%) |
| Sep 2023 | - | $61.36M(+3.4%) |
| Jun 2023 | - | $59.37M(-5.6%) |
| Mar 2023 | - | $62.92M(+9.7%) |
| Dec 2022 | $241.36M(+8.4%) | $57.34M(-8.0%) |
| Sep 2022 | - | $62.33M(+0.4%) |
| Jun 2022 | - | $62.07M(+8.9%) |
| Mar 2022 | - | $56.98M(+2.9%) |
| Dec 2021 | $222.58M(+52.2%) | $55.39M(-13.4%) |
| Sep 2021 | - | $63.99M(+19.2%) |
| Jun 2021 | - | $53.68M(+9.7%) |
| Mar 2021 | - | $48.95M(-5.7%) |
| Dec 2020 | $146.23M(+92.3%) | $51.93M(+20.1%) |
| Sep 2020 | - | $43.23M(+61.3%) |
| Jun 2020 | - | $26.80M(+6.6%) |
| Mar 2020 | - | $25.14M(+20.3%) |
| Dec 2019 | $76.02M(+35.4%) | $20.90M(-13.0%) |
| Sep 2019 | - | $24.01M(+45.9%) |
| Jun 2019 | - | $16.45M(+10.5%) |
| Mar 2019 | - | $14.88M(+1.5%) |
| Dec 2018 | $56.16M(+22.0%) | $14.66M(+3.9%) |
| Sep 2018 | - | $14.11M(-1.6%) |
| Jun 2018 | - | $14.34M(+9.9%) |
| Mar 2018 | - | $13.05M(+10.5%) |
| Dec 2017 | $46.03M(+114.0%) | $11.81M(-12.2%) |
| Sep 2017 | - | $13.46M(+34.5%) |
| Jun 2017 | - | $10.01M(-6.9%) |
| Mar 2017 | - | $10.75M(+39.8%) |
| Dec 2016 | $21.50M(-3.3%) | $7.69M(+52.0%) |
| Sep 2016 | - | $5.06M(+19.3%) |
| Jun 2016 | - | $4.24M(-6.1%) |
| Mar 2016 | - | $4.52M(-13.4%) |
| Dec 2015 | $22.25M(+37.0%) | $5.22M(-13.8%) |
| Sep 2015 | - | $6.05M(+5.3%) |
| Jun 2015 | - | $5.74M(+9.7%) |
| Mar 2015 | - | $5.24M(+15.1%) |
| Dec 2014 | $16.24M(+263.1%) | $4.55M(+18.6%) |
| Sep 2014 | - | $3.84M(-9.9%) |
| Jun 2014 | - | $4.26M(+17.8%) |
| Mar 2014 | - | $3.62M(+102.0%) |
| Dec 2013 | $4.47M(-58.8%) | $1.79M(+76.2%) |
| Sep 2013 | - | $1.02M(+8.9%) |
| Jun 2013 | - | $933.00K(+12.5%) |
| Mar 2013 | - | $829.00K(-84.0%) |
| Dec 2012 | $10.87M | $5.17M(+214.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $1.64M(-28.0%) |
| Jun 2012 | - | $2.28M(+19.8%) |
| Mar 2012 | - | $1.90M(+341.9%) |
| Dec 2011 | $3.03M(-57.0%) | $431.00K(-38.0%) |
| Sep 2011 | - | $695.50K(+2.7%) |
| Jun 2011 | - | $677.40K(+9.3%) |
| Mar 2011 | - | $619.90K(-68.6%) |
| Dec 2010 | $7.06M(-32.5%) | $1.98M(+39.5%) |
| Sep 2010 | - | $1.42M(-14.0%) |
| Jun 2010 | - | $1.65M(-9.0%) |
| Mar 2010 | - | $1.81M(-36.5%) |
| Dec 2009 | $10.46M(-42.6%) | $2.85M(+476.3%) |
| Sep 2009 | - | $494.60K(-79.7%) |
| Jun 2009 | - | $2.44M(-12.2%) |
| Mar 2009 | - | $2.78M(-21.1%) |
| Dec 2008 | $18.23M(-44.2%) | $3.52M(-14.2%) |
| Sep 2008 | - | $4.11M(-26.0%) |
| Jun 2008 | - | $5.55M(+5.1%) |
| Mar 2008 | - | $5.28M(-40.1%) |
| Dec 2007 | $32.67M(+26.2%) | $8.81M(+15.8%) |
| Sep 2007 | - | $7.61M(-18.5%) |
| Jun 2007 | - | $9.34M(+33.2%) |
| Mar 2007 | - | $7.01M(-2.4%) |
| Dec 2006 | $25.89M(-4.6%) | $7.18M(+11.2%) |
| Sep 2006 | - | $6.46M(-0.3%) |
| Jun 2006 | - | $6.47M(+11.6%) |
| Mar 2006 | - | $5.80M(-19.9%) |
| Dec 2005 | $27.15M(+43.6%) | $7.24M(+10.7%) |
| Sep 2005 | - | $6.54M(+1.3%) |
| Jun 2005 | - | $6.46M(-6.9%) |
| Mar 2005 | - | $6.93M(+1.4%) |
| Dec 2004 | $18.90M(+23.3%) | $6.83M(+13.3%) |
| Sep 2004 | - | $6.03M(+82.1%) |
| Jun 2004 | - | $3.31M(+5.4%) |
| Mar 2004 | - | $3.14M(-31.0%) |
| Dec 2003 | $15.33M(+26.6%) | $4.55M(+19.8%) |
| Sep 2003 | - | $3.80M(+119.7%) |
| Jun 2003 | - | $1.73M(+51.1%) |
| Mar 2003 | - | $1.15M(-63.0%) |
| Dec 2002 | $12.10M(+2.7%) | $3.09M(+201.0%) |
| Sep 2002 | - | $1.03M(-43.1%) |
| Jun 2002 | - | $1.81M(+80.8%) |
| Mar 2002 | - | $999.20K(-58.8%) |
| Dec 2001 | $11.78M(+88.5%) | - |
| Sep 2001 | - | $2.43M(-27.0%) |
| Jun 2001 | - | $3.32M(+38.0%) |
| Mar 2001 | - | $2.41M(+347.0%) |
| Dec 2000 | $6.25M(+157.2%) | - |
| Nov 1999 | $2.43M(-16.0%) | - |
| Aug 1999 | - | $538.70K(+12.3%) |
| Feb 1999 | - | $479.80K |
| Nov 1998 | $2.89M | - |
FAQ
- What is Aurinia Pharmaceuticals Inc. annual total operating expenses?
- What is the all-time high annual operating expenses for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. annual operating expenses year-on-year change?
- What is Aurinia Pharmaceuticals Inc. quarterly total operating expenses?
- What is the all-time high quarterly operating expenses for Aurinia Pharmaceuticals Inc.?
- What is Aurinia Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
What is Aurinia Pharmaceuticals Inc. annual total operating expenses?
The current annual operating expenses of AUPH is $192.81M
What is the all-time high annual operating expenses for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high annual total operating expenses is $244.68M
What is Aurinia Pharmaceuticals Inc. annual operating expenses year-on-year change?
Over the past year, AUPH annual total operating expenses has changed by -$51.86M (-21.20%)
What is Aurinia Pharmaceuticals Inc. quarterly total operating expenses?
The current quarterly operating expenses of AUPH is $34.62M
What is the all-time high quarterly operating expenses for Aurinia Pharmaceuticals Inc.?
Aurinia Pharmaceuticals Inc. all-time high quarterly total operating expenses is $63.99M
What is Aurinia Pharmaceuticals Inc. quarterly operating expenses year-on-year change?
Over the past year, AUPH quarterly total operating expenses has changed by -$10.80M (-23.77%)